Cyclerion Therapeutics, Inc. Soared
Wed, Nov 27, 2024 at 07:46 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) rocketted at $2.16, a gain of 58.8%. The stock appeared on our News Catalysts scanner on Fri, Nov 08, 2024 at 08:22 PM in the 'EARNINGS' category. From Wed, Nov 13, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Nov 15, 2024 at $3 with a volume of 11M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- VCI Global Limited (VCIG:NASDAQ), 125.27%
- Top KingWin Ltd (WAI:NASDAQ), 87.08%
- Unusual Machines Inc. (UMAC:NYSEMKT), 84.51%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 58.82%
- IM Cannabis Corp. (IMCC:NASDAQ), 55.04%
- HWH International Inc. (HWH:NASDAQ), 55.01%
- Procaps Group S.A. (PROC:NASDAQ), 53.68%
- Latch Inc. (LTCH:NASDAQ), 51.42%
- Movano Inc. (MOVE:NASDAQ), 49.72%
- 111, Inc. (YI:NASDAQ), 49.54%